ArticleSe pu = Chinese journal of chromatography2023
[Recent developments in the application of covalent organic frameworks in capillary electrochromatography].
Article in Se pu = Chinese journal of chromatography, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- [Recent progress in constructions and applications of chiral porous framework-based chromatographic stationary phases].Se pu = Chinese journal of chromatography · 2026Article
- Recent Developments in Capillary and Microchip Electroseparations of Peptides (2023-mid 2025).Electrophoresis · 2026Review
- [Highly sensitive detection of fluorescent whitening agents in flour using sheathless capillary electrophoresis-electrospray ionization-tandem mass spectrometry].Se pu = Chinese journal of chromatography · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capillary electrochromatography (CEC) has received increased attention from the academic community because it combines the excellent selectivity of high performance liquid chromatography (HPLC) and the high efficiency of capillary electrophoresis (CE). Selecting the most appropriate stationary phase material is crucial to achieve better separation effects in CEC. In recent years, a considerable number of materials, such as graphene oxide, proteins, metal organic frameworks, and covalent organic frameworks (COFs), have been widely used as stationary phases in CEC to further improve its separation performance and extend its scope of potential applications. Among these materials, COFs have shown great application prospects in CEC owing to their unique properties, which include high porosity, large surface area, excellent stability, tunable pore size, and high designability of the framework structure. This review systematically summarizes published papers on the development and application of COFs in CEC from 2016 to 2023. First, two COF-based capillary columns (i. e., open-tube CEC columns and monolithic CEC columns) and their preparation methods are introduced. Second, the applications of CEC based on COF stationary phases in the separation of environmental endocrine disruptors, pesticides, aromatic compounds, amino acids, and drugs, particularly chiral drugs, are systematically summarized. The separation mechanism of CEC based on COF stationary phases is also introduced. At present, the good separation ability of COF-based CEC is mainly attributed to two factors: 1) The size exclusion effect of the pores of the COF stationary phase. Because of differences in the sizes of their organic molecular building units and side chains, COFs have varying pore sizes and topological structures. Thus, target analytes smaller than the pores of the COFs can enter the frameworks and interact with them during separation. On the other hand, target analytes larger than the pores of the COFs cannot enter the frameworks and interact with them during separation; thus, they can be separated. 2) The interactions between the target analytes and side chains (e. g., hydrophobic interactions, hydrogen bonding,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.